Active Ingredient History

  • Now
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication. Trastuzumab is given by slow injection into a vein and injection just under the skin.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: Yes
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$6.0259 - $74309.4000


$145.8339 - $1181.8363
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

( hyaluronidase (human recombinant) (hylenex), trastuzumab (herceptin) - other name: trastuzumab and hyaluronidase-oysk )
( hyaluronidase (human recombinant) (hylenex), trastuzumab (herceptin), pertuzumab (perjeta) - other name: pertuzumab, trastuzumab, and hyaluronidase-zzxf )
4d5v8 | abp 980 | anti her2 | cipterbin | herceptin | r-597 | trastuzuamb | trastuzumab | trastuzumab-dkst | trastuzumab-dttb | trastuzumab-pkrb | trastuzumab-qyyp


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue